IM Cannabis to Report Fourth Quarter and Full Year 2024 Financial Results on Monday, March 31 2025 at 9:00am ET

IM Cannabis Corp. Canada United States of America New York Israel Ontario Germany

within 24 hours after the call.

Link to register for the zoom call: https://us02web.zoom.us/webinar/register/WN_RJjroBAjSOSRZLqGuM8CCw

About IM Cannabis Corp.

IMC (Nasdaq: IMCC) (CSE: IMCC) is an international cannabis company that provides premium cannabis products to medical patients in Israel and Germany, two of the largest medical cannabis markets. The Company's focus is to achieve sustainable and profitable growth in its highest value markets, Israel and Germany. The Company leverages a transnational ecosystem powered by a unique data-driven approach and a globally sourced product supply chain. With an unwavering commitment to responsible growth and compliance with the strictest regulatory environments, the Company strives to amplify its commercial and brand power to become a global high-quality cannabis player.

The IMC ecosystem operates in Israel through its commercial relationship with Focus Medical Herbs Ltd., which imports and distributes cannabis to medical patients, leveraging years of proprietary data and patient insights. The Company also operates medical cannabis retail pharmacies, online platforms, distribution centers, and logistical hubs in Israel that enable the safe delivery and quality control of IMC products throughout the entire value chain. In Germany, the IMC ecosystem operates through Adjupharm GmbH, where it distributes cannabis to pharmacies for medical cannabis patients.

Logo: https://mma.prnewswire.com/media/1742228/IM_Cannabis_Logo.jpg

Company Contact:
Anna Taranko, Director Investor & Public Relations
IM Cannabis Corp.
[phone]
[e-mail]

Oren Shuster, CEO
IM Cannabis Corp.
[phone]
[e-mail]

View original content:https://www.prnewswire.co.uk/news-releases/im-cannabis-to-report-fourth-quarter-and-full-year-2024-financial-results-on-monday-march-31-2025-at-900am-et-302406877.html